The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
The money will be donated to the United Nations Children’s Fund (UNICEF)
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers
The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte
Subscribe To Our Newsletter & Stay Updated
